Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and 2,4,5,2',4',5'-hexachlorobiphenyl

3,4-dihydroxyphenylacetaldehyde has been researched along with 2,4,5,2',4',5'-hexachlorobiphenyl in 1 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)		Trials
(3,4-dihydroxyphenylacetaldehyde)		Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)		Studies
(2,4,5,2',4',5'-hexachlorobiphenyl)		Trials
(2,4,5,2',4',5'-hexachlorobiphenyl)		Recent Studies (post-2010) (2,4,5,2',4',5'-hexachlorobiphenyl)
990505342228

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doorn, JA; Enayah, SH; Fuortes, LJ; Ludewig, G; Vanle, BC1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and 2,4,5,2',4',5'-hexachlorobiphenyl

ArticleYear
PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.
    Toxicology, 2018, 02-01, Volume: 394

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Male; Neurotoxicity Syndromes; PC12 Cells; Polychlorinated Biphenyls; Rats

2018